Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial

Stephen Couban

doi:10.1016/S1470-2045(15)00462-3

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial

Stephen Couban

Pharmacology, Toxicology and Pharmaceutics

Research output: Contribution to journal › Article › peer-review

300 Citations (Scopus)

Original language	English
Pages (from-to)	164-173
Number of pages	10
Journal	The Lancet Oncology
Volume	17
Issue number	2
DOIs	https://doi.org/10.1016/S1470-2045(15)00462-3
Publication status	Published - Feb 1 2016

ASJC Scopus Subject Areas

Oncology

Access to Document

10.1016/S1470-2045(15)00462-3

Fingerprint

Dive into the research topics of 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial'. Together they form a unique fingerprint.

Cite this

Couban, S. (2016). Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial. The Lancet Oncology, 17(2), 164-173. https://doi.org/10.1016/S1470-2045(15)00462-3

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial. / Couban, Stephen.
In: The Lancet Oncology, Vol. 17, No. 2, 01.02.2016, p. 164-173.

Research output: Contribution to journal › Article › peer-review

@article{900261fcd85c4d5ebde63f4221b5546b,

title = "Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial",

author = "Stephen Couban",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Ltd.",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/S1470-2045(15)00462-3",

language = "English",

volume = "17",

pages = "164--173",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

TY - JOUR

T1 - Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors

T2 - A randomised, controlled, open-label, phase 3, multicentre trial

AU - Couban, Stephen

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84959347862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959347862&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)00462-3

DO - 10.1016/S1470-2045(15)00462-3

M3 - Article

C2 - 26723083

AN - SCOPUS:84959347862

SN - 1470-2045

VL - 17

SP - 164

EP - 173

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this